Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Strides Pharma Science Limited
483
•Strides Pharma Science Limited•May 20, 2026

Strides Pharma Science Limited – FDA 483, May 20, 2026

Record Details

During an FDA inspection from May 12 to May 20, 2026, several significant manufacturing and quality control deficiencies were identified at the Strides Pharma Science Ltd. facility in Bangalore, India. The observations highlight failures in adhering to professional manufacturing standards intended to ensure drug safety and purity. Key issues included the use of unvalidated laboratory methods for identifying microorganisms and a lack of investigations into test results that exceeded safety thresholds. Data integrity was a major concern, as the company granted analysts excessive software permissions to modify test results and failed to retain electronic audit trails for the required duration; specifically, records were deleted after one year despite products having a five-year shelf life. Physical inspections also revealed inadequate cleaning practices, with residues and leftover medicine from previous batches found on equipment marked as "cleaned." Furthermore, the facility lacked controls to prevent the use of unauthorized production recipes and failed to conduct mandatory purity testing on high-risk ingredients used in medicines for the United States market. Under the regulatory framework for human drug manufacturing, Strides Pharma is expected to provide a formal response to the FDA. This response must detail specific corrective actions to validate laboratory procedures, enhance data security, improve equipment sanitation, and ensure thorough testing of all drug components to prevent contamination and ensure product quality.

Company
Strides Pharma Science Limited
Inspection date
May 20, 2026
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Lisa L. Flores (Consumer Safety Officer/ Federal Investigator)
  • Constance L. Richard Math
  • Rafeeq A. Habeeb (Investigator)
View Company Profile

ID · eeacb2ba-12ef-447b-8b96-f04711c33a81

Other documents for Strides Pharma Science Limited
  • 483 - 2022-12-05December 5, 2022
  • 483 - 2019-05-24May 24, 2019
  • WARNING_LETTER - 2019-02-05February 5, 2019
  • 483 - 2017-05-26May 26, 2017
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Strides Pharma Science Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.